VEGF expression correlates with neuronal differentiation and predicts a favorable prognosis in patients with neuroblastoma

[1]  W. Weng,et al.  Functional Roles of Calreticulin in Cancer Biology , 2015, BioMed research international.

[2]  M. Lai,et al.  Incidence of cancer in children aged 0-14 years in Taiwan, 1996-2010. , 2015, Cancer epidemiology.

[3]  J. Miser,et al.  Risk-directed therapy and research in neuroblastoma. , 2014, Journal of the Formosan Medical Association = Taiwan yi zhi.

[4]  Wang-Tso Lee,et al.  Calreticulin Regulates VEGF-A in Neuroblastoma Cells , 2014, Molecular Neurobiology.

[5]  C. Pan,et al.  Calreticulin activates β1 integrin via fucosylation by fucosyltransferase 1 in J82 human bladder cancer cells. , 2014, The Biochemical journal.

[6]  H. Prats,et al.  VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level , 2013, Nucleic acids research.

[7]  P. Carmeliet,et al.  VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration , 2013, Cellular and Molecular Life Sciences.

[8]  M. May,et al.  Angiogenin up‐regulation correlates with adverse clinicopathological and biological factors, increased microvascular density and poor patient outcome in neuroblastomas , 2012, Histopathology.

[9]  F. Mackenzie,et al.  Diverse roles for VEGF-A in the nervous system , 2012, Development.

[10]  K. So,et al.  Caveolin-1 Plays a Crucial Role in Inhibiting Neuronal Differentiation of Neural Stem/Progenitor Cells via VEGF Signaling-Dependent Pathway , 2011, PloS one.

[11]  J. Ambati,et al.  Neuroblastoma Progression Correlates with Downregulation of the Lymphangiogenesis Inhibitor sVEGFR-2 , 2010, Clinical Cancer Research.

[12]  J. K. Leach,et al.  Oxygen Tension Modulates Neurite Outgrowth in PC12 Cells Through A Mechanism Involving HIF and VEGF , 2010, Journal of Molecular Neuroscience.

[13]  S. Seiwerth,et al.  Vascular endothelial growth factor in children with neuroblastoma: a retrospective analysis , 2009, Journal of experimental & clinical cancer research : CR.

[14]  M. Ho,et al.  Identification of Calreticulin as a Prognosis Marker and Angiogenic Regulator in Human Gastric Cancer , 2009, Annals of Surgical Oncology.

[15]  B. Geoerger,et al.  Angiogenesis as a target in neuroblastoma. , 2008, European journal of cancer.

[16]  R. Christofferson,et al.  Angiogenesis can be reduced without significant reduction of tumor growth. , 2007, Anticancer research.

[17]  M. Memo,et al.  CEACAM1/VEGF cross‐talk during neuroblastic tumour differentiation , 2007, The Journal of pathology.

[18]  M. Chopp,et al.  Vascular endothelial growth factor mediates atorvastatin-induced mammalian achaete-scute homologue-1 gene expression and neuronal differentiation after stroke in retired breeder rats , 2006, Neuroscience.

[19]  M. Chopp,et al.  Biphasic effects of exogenous VEGF on VEGF expression of adult neural progenitors , 2006, Neuroscience Letters.

[20]  D. Lai,et al.  Calreticulin expression in neuroblastoma--a novel independent prognostic factor. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  Chao‐Ping Yang,et al.  Correlation of MYCN amplification with MCM7 protein expression in neuroblastomas: a chromogenic in situ hybridization study in paraffin sections. , 2004, Human pathology.

[22]  H. Shimada,et al.  The International Neuroblastoma Pathology Classification. , 2003, Pathologica.

[23]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[24]  G. Brodeur.  Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.

[25]  S. Aharinejad,et al.  Upregulation of vascular endothelial growth factor receptors is associated with advanced neuroblastoma. , 2002, Journal of pediatric surgery.

[26]  G. Nickenig,et al.  Destabilization of AT1 Receptor mRNA by Calreticulin , 2002, Circulation research.

[27]  W. Middlesworth,et al.  All angiogenesis is not the same: Distinct patterns of response to antiangiogenic therapy in experimental neuroblastoma and Wilms tumor. , 2001, Journal of pediatric surgery.

[28]  K. Ohnuma,et al.  Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  S. Cohn,et al.  Angiogenesis in neuroblastoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Y. Tanaka,et al.  Clinicopathologic study of mass-screened neuroblastoma with special emphasis on untreated observed cases: a possible histologic clue to tumor regression. , 2000, The American journal of surgical pathology.

[31]  A. Eggert,et al.  High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  M Opas,et al.  Calreticulin: one protein, one gene, many functions. , 1999, The Biochemical journal.

[33]  R. Johnson,et al.  KDEL proteins are found on the surface of NG108-15 cells. , 1999, Brain research. Molecular brain research.

[34]  A. Rademaker,et al.  Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  F. Berthold,et al.  Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. , 1993, Progress in clinical and biological research.

[36]  M. Pagés.  Anti-Angiogenesis in neuroblastoma , 2010 .

[37]  R. Christofferson,et al.  Importance of vascular endothelial growth factor A in the progression of experimental neuroblastoma , 2004, Angiogenesis.

[38]  Robert N. Stavins,et al.  ENVIRONMENTAL REGULATION IN THE 1990 S : A RETROSPECTIVE ANALYSIS , 2003 .

[39]  D. Ribatti,et al.  Angiogenesis and anti-angiogenesis in neuroblastoma. , 2002, European journal of cancer.

[40]  A. Llombart‐Bosch,et al.  Angiogenesis in neuroblastoma: relationship to survival and other prognostic factors in a cohort of neuroblastoma patients. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  R. Johnson,et al.  Increased calreticulin stability in differentiated NG-108-15 cells correlates with resistance to apoptosis induced by antisense treatment. , 1998, Brain research. Molecular brain research.